Research in practice: The second barrier of the human skin;Forschen für die Praxis: Die zweite Barriere der Haut

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue 3, 2010, Pages 155-158

  Baron, Jens Malte ^a   Skazik, Claudia ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Allergic contact dermatitis; Cytochrome P450 enzymes; Metabolism; Skin barrier; Skin protection; Transport proteins

Indexed keywords

CONTACT ALLERGEN; CYTOCHROME P450; HAPTEN; MULTIDRUG RESISTANCE PROTEIN;

KERATINOCYTE; MEDICAL PRACTICE; MEDICAL RESEARCH; PROTEIN TRANSPORT; REVIEW; SKIN; SKIN CELL;

ANIMALS; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; SKIN ABSORPTION;

EID: 77950451165     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07217.x     Document Type: Review

References (20)

1. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008, 17 (12 1063 1072.
2. Frosch PJ, Schulze-Dirks A, Hoffmann M, Axthelm I. Efficacy of skin barrier creams (II). Ineffectiveness of a popular "skin protector" against various irritants in the repetitive irritation test in the guinea pig. Contact Dermatitis 1993 29 (2 74 7. (Pubitemid 23226504)
3. Adams A, Gündel J, Strunk P, Angerer J. Zur Effektivitat primarpraventiver Maßnahmen bei beruflicher PAH-Exposition. Arbeitsmed Sozialmed Umweltmed 1999 34 : 97 100. (Pubitemid 29128229)
4. Korinth G, Weiss T, Penkert S, Schaller KH, Angerer J, Drexler H. Percutaneous absorption of aromatic amines in rubber industry workers: impact of impaired skin and skin barrier creams. Occup Environ Med 2007 64 (6 366 372. (Pubitemid 46867137)
5. Goh CL. Cutting oil dermatitis on guinea pig skin (I). Cutting oil dermatitis and barrier cream. Contact Dermatitis 1991 24 (1 16 21.
6. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000, 92 (16 1295 1302. (Pubitemid 30662093)
7. Zhou SF, Wang LL, Di YM, Xue CC, Duan W, Li CG, Li Y. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr Med Chem 2008 15 (20 1981 2039.
8. Baron JM, Goh LB, Denggao Y, Wolf CR, Friedberg T. Modulation of P450 CYP3A4 dependent metabolism by p-glycoprotein: Implications for P450 phenotyping. J Pharmacol Exp Ther 2001 296 : 351 358. (Pubitemid 32112460)
9. Baron JM, Höller D, Schiffer R, Frankenberg S, Neis M, Merk HF, Jugert F. Expression of Multiple Cytochrome P450 Enzymes and MDR-Associated Transport Proteins in Human Skin Keratinocytes. J Invest Dermatol 2001, 116 : 541 548. (Pubitemid 32299843)
10. Baron, JM, Wiederholt, T, Heise, R, Merk, HF, Bickers DR. Expression and function of Cytochrome p450-dependent enzymes in human skin cells. Curr Med Chem 2008, 15 (22 2258 2264.
11. Schiffer R, Neis M, Holler D, Rodriguez F, Geier A, Gartung C, Lammert F, Dreuw A, Zwadlo-Klarwasser G, Merk H, Jugert F, Baron JM. Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal keratinocytes. J Invest Dermatol 2003 120 (2 285 291. (Pubitemid 36513079)
12. Heise R, Skazik C, Rodriguez F, Stanzel S, Marquardt Y, Joussen S, Wendel AF, Wosnitza M, Merk HF, Baron JM. Active transport of contact allergens and steroid hormones in epidermal keratinocytes is mediated by multidrug resistance related proteins. J Invest Dermatol 2009 Jul 9 Epub ahead of print R, Mey J, Neis M, Marquardt Y, Joussen S, Ott H, Wiederholt T, Kurschat P, Megahed M, Bickers DR, Merk HF, Baron JM. Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D-skin models. J Invest Dermatol 2006, 126 : 2473 2480.
13. Baron JM, Heise R, Blaner W, Neis M, Joussen S, Dreuw A, Marquardt Y, Saurat JH, Merk HF, Bickers DR, Jugert FK. Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol 2005, 125 (1 143 153. (Pubitemid 40981435)
14. Bergstrom AM, Ott H, Carlsson A, Neis M, Zwadlo-Klarwasser G, Jonsson C, Merk HF, Karlberg AT, Baron JM. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J Invest Dermatol 2007, 127 : 1145 1153. (Pubitemid 46625132)
15. Hagvall L, Baron JM, Börje A, Weidolf L, Merk H, Karlberg AT. Cytochrome P450-mediated activation of the fragrance compound geraniol forms potent contact allergens. Toxicol Appl Pharm 2008, 233 (2 308 313. (Pubitemid 50295777)
16. Ott H, Bergström M, Heise R, Skazik C, Zwadlo-Klarwasser G, Merk HF, Baron JM, Karlberg AT. Cytochrome P450 induction and metabolic activation of human dendritic cells and keratinocytes exposed to carvoxime, a skin sensitizing prohapten. Chem Res Toxicol 2009, 22 (2 399 405.
17. Skazik C, Heise R, Bostanci O, Paul N, Denecke B, Kiehl K, Merk HF, Zwadlo-Klarwasser G, Baron JM. Differential expression of influx and efflux transport proteins in human antigen presenting cells. Exp Dermatol 2008, 17 : 739 747.
18. Dickel H, Bruckner T, Bernhard-Klimt C, Koch T, Scheidt R, Diepgen TL. Surveillance scheme for occupational skin disease in the Saarland, FRG. First report from BKH-S. Contact Dermatitis 2002, 46 (4 197 206. (Pubitemid 34761674)
19. Elias P. Barrier-repair therapy for atopic dermatitis: corrective lipid biochemical therapy. Expert Review of Dermatology 2008, 3 : 441 452.
20. Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009, 122 : 1285 1294.